Verici Dx Plc (VRCI) ORD GBP0.001

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Verici Dx to raise up to £5m to accelerate diagnostics roll-out
21 July 2025 13:07
(Sharecast News) - Verici Dx has announced a proposed equity fundraising of at least £5m on Monday, through a placing, subscription, and retail offer, aimed at accelerating the commercial rollout of its...
-
Verici Dx reports record Tutivia orders, downgrades revenue outlook
7 April 2025 11:26
(Sharecast News) - Verici Dx has reported its highest-ever quarterly order rate for its Tutivia transplant diagnostic test in an update on Monday, with 292 orders in the first quarter of 2025, representing a...
-
Verici Dx announces delay to Medicare determination for Tutivia test
11 October 2024 11:50
(Sharecast News) - Verici Dx, a developer of advanced clinical diagnostics for organ transplants, announced an extension to its timeline for submitting supplemental information to the US Centers for Medicare...
-
Verici Dx reaches Thermo Fisher collaboration milestone
1 July 2024 13:34
(Sharecast News) - Verici Dx, a developer of advanced clinical diagnostics for organ transplants, announced a significant milestone achievement under its agreement with Thermo Fisher Scientific on Monday.
Company announcements Announcements
-
Holding(s) in Company
1 August 2025 10:40
Verici DX
-
Holding(s) in Company
31 July 2025 17:33
Verici DX
-
Holding(s) in Company
31 July 2025 17:28
Verici DX
-
Holding(s) in Company
31 July 2025 15:24
Verici DX
-
Tutivia™ abstracts for World Transplant Congress
31 July 2025 07:00
Verici DX
-
Holding(s) in Company
30 July 2025 14:32
Verici DX
-
Holding(s) in Company
30 July 2025 14:26
Verici DX
-
Result of Annual General Meeting
30 July 2025 07:00
Verici DX
-
Result of WRAP Retail Offer
29 July 2025 07:00
Verici DX
-
Holding(s) in Company
28 July 2025 17:19
Verici DX
-
Holding(s) in Company
28 July 2025 16:55
Verici DX
-
Holding(s) in Company
28 July 2025 10:23
Verici DX
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.